Skip to content
All Podcasts – Lifestyle
Author:
Regenerative Medical Technology Group
RMTG Cellgenic Begins Commercial Activity in Colombia
September 8, 2026
Cellgenic Establishes Local Commercial Presence in Brazil
September 3, 2026
RMTG’s Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
September 1, 2026
RMTG’s Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
August 24, 2026
RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000
August 20, 2026
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
August 19, 2026
RMTG Expands Cellgenic’s Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms
August 18, 2026
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
August 5, 2026
RMTG Expands Cellgenic Operations Into Argentina, Establishing a Strategic Commercial Hub for Regenerative Medicine in Latin America
July 23, 2026
RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure
June 23, 2026
1
2
Next Page
→